Why Silencing Food Noise Requires More Than Ozempic

Understanding Food Noise in a Weight-Obsessed Culture

Food noise is rarely just about food. It manifests as the constant mental commentary: what should I eat, what shouldn't I eat, have I done 'enough' to earn this, how does my body look today? This reflects a culture deeply invested in weight and appearance. Bronwyn Wood, a credentialed eating disorder clinician (CEDC), has seen it time and time again in her clinical work spanning body image concerns, chronic dieting, disordered eating, and more severe eating disorders.

She notes how normalized this mental noise has become, particularly among women due to society's appearance-based focus. 'For many clients, the starting point isn't a diagnosis. It's exhaustion,' she said. This exhaustion stems from years of believing there's one 'right' way to eat, one 'acceptable' body size, one number that determines health. Wood's goal is to help people break that cycle, realizing they've been told this is the only way.

What Causes Food Noise?

Food noise often arises from chronic dieting, societal pressures, and internalized weight stigma. It's not merely a lack of willpower but a psychological loop reinforced by media, marketing, and even healthcare advice. GLP-1 receptor agonists like Ozempic (semaglutide) and Wegovy can physically quiet appetite signals by mimicking gut hormones that slow gastric emptying and signal fullness to the brain, potentially reducing some hunger-related thoughts. However, they don't address the deeper cultural and emotional roots.

The Rise of Ozempic and GLP-1 Medications

With the rapid rise of GLP-1 receptor agonists such as Wegovy and Ozempic—originally developed for type 2 diabetes—weight loss medications have moved from specialist settings into mainstream conversation. Social media has amplified their visibility, often framing them as a breakthrough solution. These drugs work by activating GLP-1 receptors, which regulate blood sugar, slow digestion, and curb appetite, leading to significant weight loss in clinical trials for obesity and diabetes.

While effective for some, experts caution against viewing them as a universal answer for silencing food noise. Ms Wood is careful not to position the conversation as anti-medication, because for some patients, GLP-1 medications may play a clinically appropriate role. But she highlights vulnerabilities: 'I think a lot of people can be more vulnerable or more at risk in times where their bodies might be changing. That could be perimenopause or menopause around adolescence and childbirth. It's not just bodies, but just changes and stresses in life.'

Safety Considerations with GLP-1 Agonists

Common side effects include nausea, vomiting, and gastrointestinal issues, with rarer risks like pancreatitis or thyroid concerns. Long-term data is emerging, emphasizing the need for monitoring. Patients should discuss family history of eating disorders, mental health, and realistic expectations with providers before starting.

Experts Bronwyn Wood and Courtney Nelson: A Shared Philosophy

Bronwyn Wood and her dietitian colleague Courtney Nelson are not only working one-on-one with clients but turning their attention to the broader healthcare system. Both credentialed eating disorder clinicians (CEDC), they share a philosophy: 'We have the same working philosophy,' Ms Nelson said. 'More broadly, we're both credentialed eating disorder clinicians.'

Ms Wood emphasizes that people can develop eating disorders at any stage of life, making trained experts more 'helpful than harmful.' Their approach challenges the default reliance on weight-centric care, including the growing push toward prescribing weight loss medications as a first-line response. Their message is not anti-medicine, but clear: there needs to be more to the conversation.

'A lot of what I do is try to help people break that cycle and go, "Oh, do you know what? I've been told that this is what I've had to do, and this is the only way".'

Workshops for GPs and Clinicians: Broadening the Lens

Through educational workshops for GPs, medical professionals, and exercise practitioners, Wood and Nelson promote a holistic view. They don't argue medication should never be used but ask clinicians to broaden the lens: Is the patient informed about risks and long-term considerations? Has weight stigma been addressed? Are they focusing on sustainable health behaviors rather than a number on a chart?

'I think when doctors equate people to a number, particularly on the BMI, it's just really unhelpful,' Wood said. Central to the workshops is creating 'a space where it's safe for people to be curious'—to acknowledge internal biases, question assumptions, and examine whether automatically equating higher weight with poor health serves patients effectively.

Addressing Overlooked Factors

When healthcare reduces a person to a number or reflexively moves toward weight loss, it overlooks psychological wellbeing, eating behaviors, socioeconomic factors, trauma history, and the well-documented impact of weight stigma. Ms Nelson sees clients from age 12 and up struggling with diets: 'When we're dieting and treating our body as something that needs to be smaller and be different and change, we're not really connected with it.'

Size-Inclusive Care and Body Neutrality

Size-inclusive care is critical here. 'A lot of it is about people reconnecting and understanding that bodies are diverse and they come in all shapes and sizes,' Nelson said. 'It might be loving or it could be accepting and neutral.'

They steer toward body neutrality over body positivity, which can be hijacked by weight loss communities. 'I think what we do is really a different layer... It's not so much about loving our bodies. It's more than that and in recognising that the drive for thinness and the pressure for that can actually be really harmful and that it's not really related to health. I think acceptance and neutrality, body neutrality, is where we more go. Everyone's different in that, and it's a different journey for everyone.'

Body Neutrality vs. Positivity

Body neutrality focuses on function over aesthetics—appreciating what your body does rather than how it looks. This contrasts with positivity's emphasis on love, which may not resonate during transitions. It supports metabolic health by reducing stress-eating cycles tied to appearance anxiety.

What This Means for Patients Considering Ozempic or GLP-1 Therapy

If food noise is overwhelming your daily life, start by assessing root causes. Discuss with your doctor:

• Any history of disordered eating or body image issues.
• Life stage vulnerabilities like perimenopause or postpartum changes.
• Alternatives like therapy or nutrition counseling before meds.
• Tools for tracking, such as apps like Shotlee for monitoring symptoms, side effects, or eating patterns alongside GLP-1 use.

Compare GLP-1s to lifestyle interventions: While meds offer rapid appetite suppression, behavioral therapies build lasting skills for silencing noise mentally. For type 2 diabetes patients, Ozempic's glucose benefits are proven, but weight loss alone isn't health.

Key Takeaways

• Food noise stems from cultural pressures, not just biology—Ozempic quiets physical hunger but not mental chatter.
• Experts like Wood and Nelson train clinicians via workshops to prioritize size-inclusive, stigma-free care.
• GLP-1 meds like Wegovy/Ozempic have a role but aren't first-line; screen for eating disorder risks.
• Embrace body neutrality for reconnection; everyone's path differs.
• Healthcare should address exhaustion, biases, and sustainable behaviors over BMI numbers.

Conclusion: A Holistic Path to Silencing Food Noise

Silencing food noise requires addressing the full spectrum—from psychological cycles to systemic biases—not just a prescription for Ozempic. By integrating expert insights from clinicians like Bronwyn Wood and Courtney Nelson, patients and providers can foster genuine metabolic health and wellbeing. Consult your healthcare team for personalized guidance, ensuring any GLP-1 therapy complements broader strategies for long-term peace with food and body.